Live news related to MEDINCELL stock (FR0004065605): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The Montpellier-based biopharmaceutical company continues its decline in mid-session on Tuesday, September 15, 2026, in a Paris market that is itself …
The biopharmaceutical company listed on Euronext entrusts its medical direction to an executive from Grünenthal, a specialist in clinical development …
Medincell declined sharply on Monday in an almost stable Paris market, deepening its downtrend observed over several weeks. The stock broke a technica…
The biotech company from Montpellier advances in the morning, erasing some of its weekly decline. The stock climbs to the top of the SBF 120, moving a…
The Montpellier-based biotech extends its decline during the morning, moving against a nearly flat SBF 120. The stock is now at the lower end of the b…
The biotech company from Montpellier continues its decline in early afternoon, contrary to a nearly flat SBF 120. The stock remains stuck at the lower…
The biotech company from Montpellier experiences another downturn during the session, contrary to an almost stagnant broader index. The stock continue…
The Montpellier-based biotech faces a significant halt in late morning trading, after several rebound sessions. The stock plunges to the lower end of …
The biotech company from Montpellier accelerates sharply mid-morning, extending the rebound that began late last week. The stock is among the top perf…
The biotech company from Montpellier moves forward in early afternoon, going against a downward trending Parisian market. The stock ranks among the to…
